Copy Number Variation Study of A Cohort of 46,XY DSD Patients
Mekkawy, M., Eid, O., Sayed, S., Abd-Elnaby, A., Elaidy, A., Kamel, A., Mazen, I. (2024). Copy Number Variation Study of A Cohort of 46,XY DSD Patients. EKB Journal Management System, 13(1), 39-49. doi: 10.21608/mxe.2024.394591
Mona K. Mekkawy; Ola M. Eid; Shereen A. Sayed; Azza E Abd-Elnaby; Aya Elaidy; Alaa K Kamel; Inas M. Mazen. "Copy Number Variation Study of A Cohort of 46,XY DSD Patients". EKB Journal Management System, 13, 1, 2024, 39-49. doi: 10.21608/mxe.2024.394591
Mekkawy, M., Eid, O., Sayed, S., Abd-Elnaby, A., Elaidy, A., Kamel, A., Mazen, I. (2024). 'Copy Number Variation Study of A Cohort of 46,XY DSD Patients', EKB Journal Management System, 13(1), pp. 39-49. doi: 10.21608/mxe.2024.394591
Mekkawy, M., Eid, O., Sayed, S., Abd-Elnaby, A., Elaidy, A., Kamel, A., Mazen, I. Copy Number Variation Study of A Cohort of 46,XY DSD Patients. EKB Journal Management System, 2024; 13(1): 39-49. doi: 10.21608/mxe.2024.394591

Copy Number Variation Study of A Cohort of 46,XY DSD Patients

Middle East Journal of Medical Genetics
Article 6, Volume 13, Issue 1, January 2024, Page 39-49  XML PDF (1.21 MB)
Document Type: Original Article
DOI: 10.21608/mxe.2024.394591
View on SCiNiTO View on SCiNiTO
Authors
Mona K. Mekkawy email orcid 1; Ola M. Eidorcid 1; Shereen A. Sayed1; Azza E Abd-Elnaby1; Aya Elaidy2; Alaa K Kamel1; Inas M. Mazenorcid 2
1Human Cytogenetics Department, Human Genetics and Genome Research Institute, National Research Centre, Cairo, Egypt.
2Clinical Genetics Department, Human Genetics and Genome Research Institute, National Research Centre, Cairo, Egypt.
Abstract
Background: Differences of sex development (DSD) is a group of heterogeneous conditions with a diverse pathophysiology. They are generally characterized by an abnormality of the chromosomal, gonadal or phenotypic features that typically define sex development. Aim: The study aim was to introduce Multiplex ligation-dependent Probe Amplification (MLPA) technique in the diagnostic workup of 46,XY DSD patients and to correlate genotypic abnormalities with clinical phenotype for more understanding of etiologic background. Methods: The study was carried out on thirty five 46,XY DSD patients selected from the Endocrinology clinic, Institute of human genetics and genome research, National Research Centre, Egypt. Patients underwent thorough clinical examination, hormonal assessment, pelvic ultrasonography and genitography. Laparoscopy with gonadal biopsy and histopathological evaluation were done when indicated. All patients were subjected to karyotype and MLPA analysis. Results: Clinically significant Copy number variations (CNVs) were detected in three patients in the form of SOX9 gene deletion in 2 patients, deletion of DMRT1 in 1 patient, while heterozygous duplication (of unknown significance) in HSD17B3 gene was detected in 1 patient, with an overall rate of 11.4%. Conclusion: MLPA is a robust cost-effective technique for screening of 46,XY DSD patients as a complement to Sanger sequencing. CNV analysis should be added to the first-line diagnostics in 46,XY DSD, especially if the phenotype includes malformations in other systems.
Keywords
46; XY DSD; CNV; MLPA; SOX9
Statistics
Article View: 162
PDF Download: 113